141 related articles for article (PubMed ID: 35279598)
1. Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma.
Yuan H; Wu Y; Wang J; Qin X; Huang Y; Yan L; Fana Y; Zedenius J; Juhlin CC; Larsson C; Lui WO; Xu D
Biomed Pharmacother; 2022 May; 149():112796. PubMed ID: 35279598
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
[TBL] [Abstract][Full Text] [Related]
3. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
Endocr Relat Cancer; 2014 Jun; 21(3):427-34. PubMed ID: 24803525
[TBL] [Abstract][Full Text] [Related]
4. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
Pereira SS; Máximo V; Coelho R; Batista R; Soares P; Guerreiro SG; Sobrinho-Simões M; Monteiro MP; Pignatelli D
J Cell Biochem; 2017 Aug; 118(8):2064-2071. PubMed ID: 27886397
[TBL] [Abstract][Full Text] [Related]
5. TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas.
Gupta S; Won H; Chadalavada K; Nanjangud GJ; Chen YB; Al-Ahmadie HA; Fine SW; Sirintrapun SJ; Strong VE; Raj N; Lagunes DR; Vanderbilt CM; Berger MF; Ladanyi M; Dogan S; Tickoo SK; Reuter VE; Gopalan A
Endocr Pathol; 2022 Jun; 33(2):304-314. PubMed ID: 34549366
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.
Kannengiesser C; Borie R; Ménard C; Réocreux M; Nitschké P; Gazal S; Mal H; Taillé C; Cadranel J; Nunes H; Valeyre D; Cordier JF; Callebaut I; Boileau C; Cottin V; Grandchamp B; Revy P; Crestani B
Eur Respir J; 2015 Aug; 46(2):474-85. PubMed ID: 26022962
[TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
[TBL] [Abstract][Full Text] [Related]
8. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
9. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.
Deng Z; Glousker G; Molczan A; Fox AJ; Lamm N; Dheekollu J; Weizman OE; Schertzer M; Wang Z; Vladimirova O; Schug J; Aker M; Londoño-Vallejo A; Kaestner KH; Lieberman PM; Tzfati Y
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3408-16. PubMed ID: 23959892
[TBL] [Abstract][Full Text] [Related]
10. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
[TBL] [Abstract][Full Text] [Related]
11. The Arabidopsis thaliana homolog of the helicase RTEL1 plays multiple roles in preserving genome stability.
Recker J; Knoll A; Puchta H
Plant Cell; 2014 Dec; 26(12):4889-902. PubMed ID: 25516598
[TBL] [Abstract][Full Text] [Related]
12. Regulator of telomere elongation helicase 1 gene and its association with malignancy.
Hassani MA; Murid J; Yan J
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1735. PubMed ID: 36253342
[TBL] [Abstract][Full Text] [Related]
13. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
Brown TC; Nicolson NG; Korah R; Carling T
J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
[TBL] [Abstract][Full Text] [Related]
14. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
15. Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma.
Jendrzejewski J; Tomsic J; Lozanski G; Labanowska J; He H; Liyanarachchi S; Nagy R; Ringel MD; Kloos RT; Heerema NA; de la Chapelle A
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1876-80. PubMed ID: 21900378
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
[TBL] [Abstract][Full Text] [Related]
17. Full length RTEL1 is required for the elongation of the single-stranded telomeric overhang by telomerase.
Awad A; Glousker G; Lamm N; Tawil S; Hourvitz N; Smoom R; Revy P; Tzfati Y
Nucleic Acids Res; 2020 Jul; 48(13):7239-7251. PubMed ID: 32542379
[TBL] [Abstract][Full Text] [Related]
18. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
[TBL] [Abstract][Full Text] [Related]
19. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
Zhang Y; Calado R; Rao M; Hong JA; Meeker AK; Dumitriu B; Atay S; McCormick PJ; Garfield SH; Wangsa D; Padilla-Nash HM; Burkett S; Zhang M; Kunst TF; Peterson NR; Xi S; Inchauste S; Altorki NK; Casson AG; Beer DG; Harris CC; Ried T; Young NS; Schrump DS
PLoS One; 2014; 9(7):e101010. PubMed ID: 24983628
[TBL] [Abstract][Full Text] [Related]
20. Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.
Ley B; Torgerson DG; Oldham JM; Adegunsoye A; Liu S; Li J; Elicker BM; Henry TS; Golden JA; Jones KD; Dressen A; Yaspan BL; Arron JR; Noth I; Hoffmann TJ; Wolters PJ
Am J Respir Crit Care Med; 2019 Nov; 200(9):1154-1163. PubMed ID: 31268371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
